- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01513954
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
January 17, 2012 updated by: Red Rock Fertility Center
The purpose of this study is to determine whether progesterone hormone levels differ following egg retrieval with a single lumen needle compared with a double lumen needle.
These levels will be measured on several days before and after egg retrieval.
The progesterone levels in each IVF group will also be compared to the group of women who are having IUI.
In addition, these progesterone levels will be correlated with pregnancy outcomes.
Study Overview
Status
Unknown
Conditions
Detailed Description
This is a prospective randomized trial consisting of 3 groups of patients.
Following a long lupron protocol IVF cycle there is a need for supplemental progesterone.
The purpose of this study is to determine what range of serum levels should be observed when differing methods of egg aspiration have been administered and whether or not there is a correlation with outcomes or pregnancies.
Study Type
Observational
Enrollment (Anticipated)
450
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eva D Littman, M.D.
- Phone Number: 702-262-0079
- Email: drevalittman@hotmail.com
Study Contact Backup
- Name: Maria (Charry) R Lopez, M.D.
- Phone Number: 702-262-0079
- Email: charry@lasvegasfertility.com
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89148
- Recruiting
- Red Rock Fertility Center
-
Contact:
- Maria (Charry) R Lopez, MD
- Phone Number: 702-262-0079
- Email: charry@lasvegasfertility.com
-
Contact:
- Eva D Littman, MD
- Phone Number: 702-262-0079
- Email: drevalittman@hotmail.com
-
Principal Investigator:
- Eva D Littman, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 37 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
IUI patients and IVF patients following a long lupron protocol cycle
Description
Inclusion Criteria:
- Ages between 21-37
- Cycle Day 3 FSH between 2-12
- History of regular menstrual cycles between 24-34 days
Exclusion Criteria:
- Previous IVF failure
- Severe male factor
- Severe obesity, BMI > 40
- More than 20 follicles on ultrasound prior to retrieval
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
IVF population
Long Lupron IVF Population
|
IUI patients
Patients undergoing IUI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eva D Littman, M.D., Red Rock Fertility Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Anticipated)
January 1, 2013
Study Completion (Anticipated)
June 1, 2013
Study Registration Dates
First Submitted
January 17, 2012
First Submitted That Met QC Criteria
January 17, 2012
First Posted (Estimate)
January 20, 2012
Study Record Updates
Last Update Posted (Estimate)
January 20, 2012
Last Update Submitted That Met QC Criteria
January 17, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20111821
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Female
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Newlife Fertility CentreRecruitingInfertility | Infertility,Female | Infertility Unexplained | Infertility of Uterine Origin | Infertility; Female, NonimplantationCanada
-
Cairo UniversityCompleted
-
Navy General Hospital, BeijingUnknownFemale Infertility Due to Nonimplantation of OvumChina
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Woman's Health University Hospital, EgyptCompletedFemale Infertility Due to Diminished Ovarian ReserveEgypt
-
Woman's Health University Hospital, EgyptCompleted